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Abstract. Whereas brefeldin A (BFA) protected a num-
ber of cell lines against the protein toxin ricin, two of
the cell lines tested were not protected but rather sen-
sitized to ricin by BFA. EM studies revealed that upon
addition of BFA the Golgi stacks in cells which were
protected against the toxin rapidly transformed into a
characteristic tubulo-vesicular reticulum connected to
the endoplasmic reticulum, and subcellular fractiona-
tion experiments showed that galactosyl transferase
disappeared from the Golgi fractions where it was nor-
mally located. EM and subcellular fractionation also
indicated that in contrast to the Golgi stacks, the trans-
Golgi network (TGN) remained intact and that inter-
nalized ricin was still localized in the TGN both when
BFA was added before and after the toxin. Thus, BFA
does not prevent fusion of ricin-containing vesicles
number of toxic proteins such as ricin, abrin, modec-
cin, Shiga toxin, and diphtheria toxin inhibit pro-
tein synthesis after entry into the cYtosol (for review
see reference 17). The entry involves endocytosis of the tox-
ins and translocation of the enzymatically active A moiety
to the cytosol from an intracellular compartment (43). In the
case of ricin it has been demonstrated both by EM and by
subcellular fractionation that the toxin is transported to the
Golgi apparatus (28, 32, 40), mainly to the trans-Golgi net-
work (TGN)' (42) . There is evidence that ricin A chain
translocation takes place in the TGN or in a postTGN com-
partment, and this seems to be the case for at leastone other
toxin, i .e., Shigatoxin (32) . The exception is diphtheria tox-
in, where translocation of the enzymatically active chain
seems to occur from endosomes (24, 27).
Drugs affecting the intracellular compartments involved in
toxin entry are likely to affect the sensitivity of cells to
toxins. The drug brefeldin A (BFA) has a marked effect on
the Golgi complex in a number of cell types. Newly formed
membrane proteins as well as virus proteins are retained in
the ER (5, 13, 14). There is a rapid disorganization of Golgi
stacks and a redistribution of Golgi membrane and proteins
1. Abbreviations used in this paper: BFA, brefeldin A; TGN, trans-Golgi
network.
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with the TGN, and unlike resident proteins in Golgi
stacks, ricin is not transported back to ER upon
treatment of cells with BFA. Two kidney epithelial cell
lines, MDCK and PtK2, were not protected against ri-
cin by BFA, and EM studies of MDCK cells revealed
that BFA did not alter the morphology of the Golgi
complex in these cells. Also, subcellular fractionation
revealed that, in contrast to the other cell types tested,
the localization of galactosyl transferase in the gradi-
ents was not affected by BFA treatment. The data show
that there is a correlation between BFAinduced disas-
sembly of the Golgi stacks and protection against ricin,
and they demonstrate that the structural organization
of the Golgi apparatus is affected by BFA to different
extents in various cell lines.
into the ER and nuclear envelope. BFA-induced changes in
the Golgi complex has also been reported in a cell-free sys-
tem (18). However, the structural pattern of this process
varies somewhat from one report to another (6, 7, 13-15, 36,
39,45).
We have in the present work studied the transport of ricin
in various BFA-treated cell types and correlated the effects
of BFA-treatment on Golgi structure with the ability of ricin
to inhibit protein synthesis. We show that most cell lines are
protected against ricin by BFA, and EM studies of four of
these cell lines (T47D, A431, HEp-2, and Vero) reveal that
the Golgi stacks but not the TGN disappear upon addition
of BFA. Interestingly, ricin is still transported to the TGN.
In contrast, MDCK and PtK2 cellsare not protected against
ricin by BFA, and there is no morphological effect of BFA
on the Golgi apparatus of MDCK cells.
Materials andMethods
Materials
HRP type V1, pronase, diaminobenzidine, SPDP (3-[2 pyridyodithiol-
propionic acid N-hydroxysuccinimideester), Hepes, andTris were obtained
from Sigma Chemical Co., St. Louis, MO. BFA was obtained from
Epicentre Technologies, Madison, Wl. Nycodenz was obtained from
NYCOMED, Oslo, Norway; [3H]leucine and Na1211 were from the Radio-
971chemical Centre, Amersham, UK. Shiga toxin was a generous gift from Dr.
J. E. Brown. Ricin-HRP conjugates were prepared by the SPDP method
as previously described (40).
Cells
Thedifferent cell lines were obtained from thefollowing sources: Vero cells
and HEp-2 cells were obtained from Flow Laboratories, Irvine, Ayrshire,
Scotland; A431, Caco-2, L929, PtK2, and MCF7 cells were from the
American Type Culture Collection, Rockville, MD; MDCK and BHK cells
were given to us by Dr. Kai Simons, EMBL, Heidelberg, Germany; NRK
cells were obtained from Dr. T. Ege, NYCOMED; U-20S cells were from
Dr. G. F. Vande Woude, National Cancer Institute, Frederick, MD; HeLa
S3 cellswere from Dr. Laland, University ofOslo, Norway; and T47D cells
were obtained from the Fibiger Laboratory, Denmark (11). Cells were
grown in Costar 3000 flasks (Costar, Badhoevedorp/The Netherlands) or
T25 flasks (NUNC, Roskilde, Denmark) and in the case of MDCK cells
(strain 1), also onpolycarbonate filters (Costar Transwell, pore size0.4 ,um,
diameter 24.5 mm). The cells were routinely seeded at a density of 106 per
filter and used for experiments 2-5 days later (44). All filters used for ex-
periments had a transepithelial resistance of at least 1,000 SZ cm2 as mea-
sured with the Millicell-ERS equipment (Millipore Continental Water Sys-
tems, Bedford, MA) also at the end ofthe experiments. The medium used
was DME (3.7 g/1 sodium bicarbonate) (Flow Laboratories) containing 5%
FCS (Gibco, Ltd., Paisley, Scotland) and 2 MM r.-glutamine (Gibco, Ltd.).
In the case ofthe PtK2 and CaCo-2 cells the medium contained 10% FCS
and nonessential amino acids (Gibco, Ltd.).
MeasurementofCytotoxicEffect
After incubation ofcells with toxin as described in legends to figures, the
medium was removed, and the cells were incubated in the same medium
(no unlabeled leucine) for 10 min at 37°C with 1 pCi of [3H]leucine per
ml . Then the solution was removed, and the cells were washed twice with
5 % (wt/vol) TCA and solubilized in KOH (0.1 M). Finally, the acid-
precipitable radioactivity was measured. The experiments were carried out
in duplicate. The difference between duplicates was <10% of the average
value.
MeasurementofReceptor-mediatedEndocytosis of
1251-7yansferrin and 125I-Ricin
The amount of internalized transferrin was measured as described by
Ciechanover et al. (4) . Endocytosis of 1251-labeled ricin was measured as
the amount of toxin that could not be removed with lactose as previously
described (23).
Subcellular Fractionation ofCells
The cells (107 cells growing in T75 flasks) were scraped offthe plastic with
a rubber policeman after the addition of homogenization buffer (H-buffer:
0.3 M sucrose, 3 mM imidazole, pH 7.4). The pooled cells were pelleted
by centrifugation for 10 min at 100 g. The pellet was resuspended in 1 nil
H-buffer and homogenized by passing it 10 times up and down through a
1-ml blue tip on a Gilson pipette, followed by six times through a 1-ml sy-
ringe with a 22G 1 1/4 needle before homogenization by six strokes in a
tight-fitting Dounce homogenizer. The homogenate was centrifuged at
2,500 rpm for 10 min in 1.5 ml Eppendorf tubes in a centrifuge, (model
5415, Eppendorf) to obtain a nuclear pellet and a postnuclear supernatant.
The postnuclear supernatant was subjected to discontinuous gradient cen-
trifugation in a system similar to that reported by Sandberg et al . (22). In
the bottom of SW 40 tubes, gradients were made of 4.5 ml light solution
(1.15 M sucrose, 15 mM CsCl) and 1.5 ml heavy solution (1.15 M sucrose,
15 mM CsCl, 15 % Nycodenz [wt/vol]). The gradients were made in a Bio-
comp Gradient Master, NYCOMED, Oslo (angle 74, speed 16, time 2 min,
45 s). Postnuclear supernatant (5.6 parts) was mixed with 2 M sucrose, 10
mM CsCl (4.4 parts), usually a total of 1.5 nil, and layered on top of the
gradient. This was again overlayed with 3 ml 0.9 M sucrose, and finally 1-2
ml of0.3 M sucrose. After 4 h at 33,000 rpm, the gradients were fraction-
ated (25-30 fractions) and analyzed with respect to marker distribution.
EnzymeAnalysis
HRP was measured according to Steinman et al. (37), UDP-galactose/gly-
coproteingalactosyl transferase according to Brandli et al. (2), esterase and
S-N-acetyl-glucosaminidase according to Beaufay et al. (1).
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Processingfor Electron Microscopy
Cells grown in monolayers in T-25 flasks were incubated with BFA (5
pg/ml) alone or with various combinations of BFA and ricin-HRP as de-
scribed in the text. Thereafter the cells were fixed with 2 % glutaraldehyde
in 0.1 M Na-cacodylate buffer, pH 7.2, for 60 min at room temperature,
washed with PBS, and incubated with diaminobenzidine-H202 as previ-
ously described (40). The cells were postfixed with OsO4, treated with 1%
uranyl acetate in distilled water, embedded in Epon, cut at 50 run, and ex-
amined in an electron microscope (model 100 CX, JEOL) without further
contrasting (40) .
Results
EffectsofBFA on theStructureofthe Golgi Complex
in Various CellLines
In this study the effect of BFA on the organization of the
Golgi complex was examined ultrastructurally in five differ-
ent cell lines: Vero, T47D, A431, HEp-2, and MDCK (see
Table I) . The key observations were identical for the four
first-mentioned lines although Vero cells have small Golgi
complexes without any marked stacked appearance or dis-
tinctTGN, and T47D cells are equipped with very extensive
Golgi complexes often with distinct stacks and TGN.
Within 5 min of BFA treatment, most Golgi stacks had
vesiculated and sometimes formed tubulo-vesicular appen-
dices emerging from the lateral border of the stacks. After
15 min with BFA no structures resembling typical Golgi
stacks could be identified in the cells, but a tubulo-vesicular
Golgireticulum (which was neverobserved in control cells)
became very conspicuous (Fig. 1) . After 30-60 min this
Golgi reticulum had often "condensed" into some discrete,
globular tubulo-vesicular lumps intimately associated with
elements of the ER (Fig. 1). This was in particular evident
in Vero cells where the small Golgi-derived reticula were
well suited for serial section analysis (Fig. 2). Often vesicles
and tubulo-vesicular processes appeared to connect these
lumps with ER cisterns, in agreement with the concept of
BFA-induced retrograde transport of Golgi membrane and
content into the ER (13, 14, 18). The tubulo-vesicular Golgi
reticulum which often occupied very large parts of the T47D
cells after 15-60 min of BFA exposure (Fig. 3), gradually
decreased in size with increasing time of BFA exposure. Af-
ter 4-8 h of BFA exposure, the tubulo-vesicular Golgi reticu-
lum had disappeared completely (data not shown) . Under
these conditions the ER was often highly dilated. Moreover,
changes in the morphology of mitochondria became appar-
ent. The BFAinduced transformation of Golgi stacks into
tubulo-vesicular reticula was reversible. Thus, when cells
were first incubated for 30 min in the presence of BFA and
then washed and further incubated without BFA, typical
Golgi complexes (stacks) were readily observed within 30
min (data not shown).
In contrast to our observations on Vero, T47D, A431, and
HEp-2 cells, MDCK cells appeared morphologically un-
affected by BFA treatment. Thus, even after 60 min at 37°C
with 5 lAg/ml BFA, normally appearing Golgi stacks with the
same size and frequency as in controls could be identified
(not shown), and no tubulo-vesicular reticula were observed.
The characteristic tubulo-vesicular reticulum reported
here closely resembles the tubule network described recently
in a cell-free system where the assembly of nonclathrin-
coated Golgi transport vesicles was prevented by BFA treat-
972Figure 1. Effect ofBFA treatment on the Golgi complex in Vero cells. (a) The Golgi-derived tubulo-vesicular reticulum (Go) after a 15-min
exposure to 5 Ag/ml BFA. (b and c) Sections no. 5 and 8 of a series of consecutive sections . The tubulo-vesicular Golgi reticulum is a
characteristic, globular organelle aftera 60-min exposure toBFA . Note the close relationsbetween the Golgi reticulumand the endoplasmic
reticulum (Er) . Bars, 0.25 Am.
ment (18) . In the cell-free Golgi system, however, structural
relations to the ER could not be dealt with, and also no dis-
tinction between the Golgi stack and the TUN was made. It
has been reported that resident Golgi enzymes of cis-,
medial-, and trans-Golgi cisterns are transported back to the
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ER and nuclear envelope during BFA treatment whereas a
marker enzyme of the TGN is not (3, 5, 13) . In contrast,
Fujiwara et al . (7) found in rat hepatoma cells that the rapid
BFA-induced disassembly of the Golgi complex included the
TGN, leaving no Golgi structures distinct from the ER . To
973Figure 2 . Six consecutive sections through a tubulo-vesicular Golgi reticulum (Go) of a Vero cell exposed to 5 pg/ml BFA for 60 min.
The connections to the endoplasmic reticulum (Er) are shown (arrows) . Bar, 0.25 jm .
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974Figure 3. 'llibulo-vesicular Golgi reticula (Go) in T47D cells exposed to 5 Ag/ml BFA for (a) 15 or (b) 60 min . Er, endoplasmic reticulum .
Bar, 0.25 jm .
further study whether the TGN of BFA-treated cells was in-
cluded in the tubulo-vesicular reticulum or remained dis-
tinct, we allowed cells to endocytose monovalent ricin-HRP
before adding BFA . Ricin (and monovalent ricin-HRP) is
known to be transported to the TGN and can therefore be
used as a marker for this compartment (28, 40, 42) (Fig . 4) .
The rationale was that if the TGN was incorporated in the
tubulo-vesicular reticulum and thus moved backwards into
theER and the nuclear envelope, these compartments should
be labeled with ricin-HRP It turned out, however, that in
BFA-treated T47D cells previously loaded with ricin-HRP,
no labeling of the tubulo-vesicular reticulum was obtained
(Fig . 4) . Similarly, ricin-HRP labeling of theER and the nu-
clear envelope was never seen (Fig . 4) . In contrast, struc-
tures closely resembling TGN of control cells were often dis-
tinctly labeled (Fig. 4) . Such structures were not labeled
when the cells were incubated with HRP which detects all
endocytic compartments but is not transported to the TGN
(8, 41) (Fig . 5) . Our results therefore suggest that whereas
cisterns ofthe Golgi stack (cis-to-trans) are transformed into
the tubulo-vesicular reticulum and transported in a retro-
grade way to theER uponBFA treatment, the TGN becomes
separated from the Golgi reticulum and remains intact .
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Similar TGN-like structures could also be labeled when
T47D cells were BFA-treated before exposure to ricin-HRP
To confirm that ricin in BFA-treated cells enters theTGN and
stays there, cell fractionation was used to study the distribu-
tion of galactosyl transferase as well as I'll-labeled ricin in
control and BFA-treated cells .
SubcellularFractionation of Cells Treated with BFA
We have earlier shown that subcellular fractionation can be
performed in such a way that the Golgi marker galactosyl
transferase becomes separated from endosomes, lysosomes,
and ER in MDCK cells (32) . We have now found that the
same method can be applied toT47D (Fig . 6) andA431 cells
(data not shown), and we have therefore used this system to
study changes in the localization of different markers after
BFA treatment . To fractionate the cellswe have used a linear
gradient in the bottom of the tube, then a load zone, and on
the top, two layers of sucrose . In control cells not treated
with BFA, endosomes, lysosomes, and ER move down into
the gradient (peak III in Fig . 6), whereas the Golgi markers
move upwards (peak I in Fig. 6) . Upon BFA treatment of
T47D cells (Fig . 6) and A431 cells (data not shown) galac-
975Figure 4 . (a and b) Organization of the Golgi complex of control T47D cells incubated with ricin-HRP for 60 min at 37°C . The ricin
conjugate clearly outlines the TGN, whether it is of cisternal (a) or tubular (b) appearance (cf. reference 9), while the Golgi stacks (GoS)
are unlabeled. (c andd) From an experiment in which the TGN ofT47D cells has been labeled by ricin-HRP for 60 min and thereafter
exposed to BFA for 60 min . It is obvious that neither the tubulovesicular Golgi reticulum (Go), the endoplasmic reticulum (Er), nor the
nuclear envelope (Ne) become labeled by the ricin conjugate . Bars, 0.25 Am.
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976Figure5 . Control T47D cells incubated withHRP for 60 min at 37°C . Labeling ofendosomes/lysosomes (*) is distinct, whereas the Golgi
complexes (Go) are unlabeled . Bars, 0.25 Am .
tosyl transferase was shifted to a different position in the gra-
dient . Instead ofmoving upwards from the load zone, the en-
zyme now moved downwards. On the other hand, there was
no change in the localization of 'III-labeled ricin (Fig . 6) .
As in control cells, a fraction of the toxin moved upwards in
the gradients also when the cells were incubated withBFA,
demonstrating that incoming vesicles containing ricin can
still fuse with theTGN . Ricin transport to theTGN was mea-
sured in a number ofdifferent experiments, and the data are
summarized in Fig . 7. As shown, BFA treatment seems to
give only a slightreduction in the amount ofricin transported
to the TGN . Transport of ricin to the TGN was measured
bothwhenBFA was present during the incubation with ricin
and after a preincubation withBFA which was then removed
before the addition of ricin . Also, when ricin was first al-
lowed to accumulate in the TGN and BFA was then added,
ricin stayed in the Golgi fractions . As shown in Fig. 7, we
found thatN5% of internalized ricin was present in the Golgi
apparatus, a value identical to that previously obtained by
quantitative immunogold labeling (42) .
In contrast to the results obtained with T47D and A431
cells, there was no change in the localization of any marker
in the MDCK cells (Fig . 8) .
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The Effect ofBFA on the Sensitivity ofCells to Ricin
To study the effect ofBFA on the sensitivity of different cell
types to ricin, we preincubated cells for 30 min at 37°C
with the indicated concentrations of BFA, added increasing
concentrations of toxin, and measured the protein synthesis
3 h later. As shown in Fig . 9 and Table I, Vero, T47D, A431,
and a number of other cell types were protected against
ricin upon addition ofBFA . Vero cells were also protected
by BFA against modeccin, Shiga toxin, abrin, volkensin, and
viscumin (data not shown) . All these toxins may depend on
transport to the Golgi apparatus for entry into the cytosol .
In contrast, there was no effect ofBFA on the intoxication
with diphtheria toxin, which enters the cytosol from endo-
somes (27) .
The protective effect ofBFA was not due to inhibition of
transport ofnewly synthesized toxin receptors to the cell sur-
face since the drug protected even after prebinding of the
toxins (data not shown) . BFA protected well even when
added several minutes after ricin, an observation that is in
agreement with the rapidly observed changes in the Golgi
apparatus upon addition ofthis drug . Also, the effect ofBFA
on the Golgi apparatus seems to be rapidly reversible (13) .
The same was the case with the effect on toxicity, the cells
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Figure 6. Effect of BFA on the subcellular distribution of different markers in T47D cells. The cells were incubated in the absence and
presence of BFA (1 )Ag/ml) and 1251-labeled ricin (100 ng/ml; 40,000 cpm/ng) for 60 minat 37°C. In experiments in which ricin had been
added, cell surface-bound toxinwasthen removedwith lactose, and the cellswere homogenized and fractionated as describedin Materials
and Methods. The amounts of 1251-labeled ricin and marker enzymes in the different fractions were measured as described in Materials
and Methods. (A and B) No BFAadded; (C andD) BFA added. (o) 1251-labeled ricin; (A) HRP; (m) galactosyl transferase; (o) a-hexos-
aminidase. (1) Golgi fractions; (II) load zone; (III) endosomes and lysosomes.
were as sensitive as before when BFA was removed after a
1-h incubation in the presence of thedrug (datanot shown).
Although the only reported effects of BFA until now are
on the Golgi apparatus, we tested the effect of the drug on
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endocytosis after a 3-h incubation, since a reduced uptake
from the cell surface would affect translocation of toxin to
the cytosol. However, BFAtreatmenthadno effect on theup-
take of transferrin whichis takenup by clathrin-coated vesi-
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Figure 7. Effect ofBFA on the
localization of 1251-ricin in the
Golgifractions ofT47D cells.
T47D cells (107 cells growing
in T-75 flasks) were incubated
in a Hepes-containing medi-
um at 37°C with and without
BFA (1 Ag/ml) as indicated
in the figure. Then 1251-ricin
(40,000 cpm/ng; 100 ng/ml)
was added, and the incuba-
tion wascontinuedfor 60 min
more before cell surface-
boundtoxinwasremovedwith
lactose and thecells were ho-
mogenized as described in
Materials and Methods. In D,
the incubation was continued
for an additional 30 min in
thepresence ofBFAbefore the
cells were homogenized. The
results shown are the mean
values + SD. (n = 5 in A and
B; n = 3 in C and D).
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Figure8 . Effect ofBFA on the subcellular distribution of different markers in MDCK cells . The experiment was performed in the same
way as described in thelegend to Fig. 6. (A and B) NoBFA added ; (C and D) BFAadded. (o) I'll-labeled ricin ; (A)HRP; (a) galactosyl
transferase; (o) (3-hexosaminidase . (I) Golgi fractions ; (II) load zone ; (III) endosomes and lysosomes.
cles (10) and it had no effect on the uptake of ricin which is
internalized both by clathrin-coated vesicles and from un-
coated areasofthe cell membrane (26, 29-31) . Also, normal
appearing endosomes and lysosomes containing ricin-HRP
1 10 100 1000 1 10 100 1000
Ricin concentration (ng/ml)
Figure 9 Effect of BrefeldinA on the sensitivity of (A) Vero, (B)
T47D, (C) A431, and (D)MDCK cells to ricin. Cells growing in
24-well disposable trayswere incubated in aHepes-containing me-
dium with and without the indicated concentrations ofBFA for30
min at 370C . Then increasing concentrations of toxin were added
andthe cellswere incubated for3h at 370Cbefore protein synthesis
was measured as described in Materials and Methods. (o) No
BFA; (v) 5 pg/ml BFA; (A) 1 Rg/ml BFA; (e) 0.1 pg/ml BFA; (o)
0.01 pg/ml BFA.
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were observed by EM inBFAtreated cells (datanot shown) .
Thus, it seems likely that theprotection against ricin byBFA
is dueto its effect on the Golgiapparatus, and that the change
in this compartment somehow interferes with the transloca-
tion of the toxin A chains to the cytosol .
Addition ofBFA toMDCKandPtK2 cells gave no protec-
tion against ricin (Fig . 9 and Table I), the cells were rather
sensitized to ricin . In differentexperiments the sensitization
Table 1 . Effect ofBrefeldinAon the Sensitivity of
Different Cell Lines to Ricin
979
Cells growing in 24-well disposable trays were incubated with 1-5 pg/ml BFA
in a Hepes-containing medium for 30 min. Then increasing concentrations of
ricin were added, and the protein synthesiswas measured 3h later as described
in Materials and Methods.
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Cell line Tissue of origin Protection
MDCK I Madin-Darby canine kidney -
MDCK II Madin-Darby canine kidney -
PtK2 Potoroo kidney -
T47D Human mamma carcinoma +
HEp-2 Human carcinoma laryngis +
A431 Human epidermoid carcinoma +
Vero African green monkey kidney +
HeLa S3 Human cervical carcinoma +
L929 Murine fibroblast +
NRK Normal rat kidney +
Caco-2 Human intestine +
BHK Baby hamster kidney +
MCF7 Human adenocarcinoma +
U20S Human osteogenic sarcoma +varied somewhat, but in all cases 4-10 times less ricin was
required to give a 50% reduction of the protein synthesis in
BFA-treated cells compared to nontreated cells. Similarly,
MDCK cells were not protected by BFA against abrin and
modeccin (data not shown) . Even when the cells were prein-
cubated for 4 h in the presence of BFA before ricin was
added, there was no protection against the toxin . The lack
of protection was not due to inactivation ofBFA by the cells.
The cells were still sensitized when the drug was added sev-
eral times during the experiment and, furthermore, medium
from MDCK cells incubated with BFA was, when trans-
ferred to Vero cells, still able to protect these cells against
ricin. BFA was unable to protect MDCK cells against ricin
underall culture conditions studied. The drug did not protect
newly trypsinized cells against ricin, nor did it protect pola-
rized MDCK cells grown on polycarbonate filters. As men-
tioned above, BFA actually sensitized MDCK cells to ricin.
We have previously shown that cycloheximide sensitizes
Vero and Hela cells to ricin (28). Cycloheximide also sensi-
tized MDCK cells to the toxin. However, the combination
of BFA and cycloheximide did not sensitize more than addi-
tion of either drug alone (data not shown), suggesting that
the reason for the sensitization may be the same in the two
cases. BFA in fact also inhibited the growth of MDCK cells
(data not shown) . However, a long-term incubation with BFA
could induce changes of a different type than the short-term
effects here described.
Discussion
The main finding in the present paperis that the effect ofBFA
on Golgi structure correlates with the toxic effect of ricin,
and that cell lines respond quite differently to BFA treatment.
This latter observation may reflect differences in the organi-
zation or dynamics of the Golgi apparatus.
Protection against ricinby BFA correlates with the forma-
tion of a tubulo-vesicular reticulum in several, quite different
cell lines. This reticulum closely resembles the tubule net-
work generated from Golgi stacks by BFA treatment in a
cell-free system made from CHO cells (18). In this system
Golgi stack elements apparently fuse and allow exchange of
Golgi molecules by lateral diffusion . Our present observa-
tions establish this tubulo-vesicular Golgi reticulum as a dis-
tinct intermediate station during the BFA-induced retrograde
movement of Golgi elements into the ER.
Several lines of evidence have suggested that the TGN is
structurally and functionally different from the cis-trans
stacks (3, 9), and Chege and Pfeffer (3) found that mannose
6-phosphate receptors were able to reach the TGN after en-
docytosis in BFA-treated cells. Similarly, our present studies
with both EM and cell fractionation indicate that even when
the stacked cisterns have become transformed into the
tubulo-vesicular reticulum and moved in a retrograde way to
the ER, the TGN remains apparently intact, and can still be
reached by endocytosed molecules, in this case the protein
toxin ricin. Ricin-HRP has thus allowed us to visualize the
TGN after BFA treatment.
BFA has been reported to inhibit sialylation of vesicular
stomatitis virus G-protein (5), T cell antigen receptor-c«
chain (13), class I-restricted antigen (16), and the EGF
receptor (35) . These results are in agreement with the notion
that sialylation occurs in the TGN, and that BFA treatment
prevents the contact between substrate and enzyme because
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TGN stays intact. However, it was recently shown that BFA
has different effects on sialylation depending on the linkage
type of the oligosaccharides. N-linked saccharides were not
sialylated whereas O-linked saccharides were sialylated in
the presence ofBFA (35) . This suggests that the different en-
zymes responsible for sialylation may have different localiza-
tion in the Golgi complex and could be the explanation for
the sialylation ofO-linked carbohydrates ofglycophorins oc-
curring in the presence of BFA (39) . Roth and co-workers
(20, 21) in fact reported that R-galactoside a2,6-sialyltrans-
ferase is localized significantly in the trans-Golgi cisternae
in addition to the TGN in various cells examined, and Takami
et al . (38) reported that sialyltransferase was localized both
in the trans-Golgi stack and in TGN in choriocarcinoma
cells. They also reported sialylation of N-linked carbohy-
drates in the same cells after BFA treatment. Thus, sialyl-
transferase is not necessarily a good marker to test the in-
tegrity of TGN after for instance BFA treatment.
The fate of the TGN during BFA exposure is in particular
interesting in relation to the ability of ricin to inhibit protein
synthesis. Hence ricin A chain has to be translocated from
an intracellular compartment (25), and different lines of evi-
dence suggest that ricin is translocated to the cytosol from
the TGN or from a postTGN location (28, 33, 43) . BFA was
in fact recently found to protect Vero cells and BHK cells
against ricin (33, 46), and it was suggested by Yoshida et al.
(47) that BFA inhibits transport of ricin to the TGN (8) and
that this could be the explanation for the protection. How-
ever, as shown in the present study, ricin seems to enter the
TON also after BFA treatment. One can therefore only spec-
ulate about the reasons for the protection. The TGN in BFA-
treated cells seems to end up as a separate organelle which
can no longer participate in retrograde transport of mole-
cules to Golgi stacks. Also, it seems reasonable to believe
that the formation of exocytic vesicles is rapidly abolished.
Therefore, ifricin normally enters the cytosol at a postTGN
stage, BFA would protect. Another possibility is that ricin
has to be modified by Golgi enzymes before it enters the
cytosol, and that BFA treatment leads to removal ofthese en-
zymes, which may be transferred back to the ER. Although
TGN seems to be unaffected morphologically, we can not ex-
clude the possibility that BFA changes the composition of
this organelle. It is known from other studies that proteolytic
processing can occurin the Golgi apparatus (12, 19, 34), and
ricin may have to undergo proteolytic processing before be-
ing translocated.
The finding that BFA actually sensitized the MDCK cells
to ricin shows that the drug affects also these cells, although
in a different manner than it affects most other cell types
tested . In spiteof the lack of structural changes of the Golgi
stacks, recent experiments reported by Dr. Ira Mellman and
co-workers clearly show that BFA can affect intracellular
transport in MDCK cells (personal communication from Dr.
Ira Mellman, Yale University, New Haven, CT) . Their
results show that transcytosis of dimeric IgA is strongly in-
hibited in MDCK cells upon addition ofBFA. Furthermore,
the inhibition of cell growth caused by BFA, although being
a long-term effect, also shows that the drug affects these
cells.
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